Accéder au contenu
Merck

In vitro screening of Fe2+-chelating effect by a Fenton's reaction-luminol chemiluminescence system.

Luminescence : the journal of biological and chemical luminescence (2014-01-10)
Mitsuhiro Wada, Hiroaki Komatsu, Rie Ikeda, Talal A Aburjai, Suleiman M Alkhalil, Naotaka Kuroda, Kenichiro Nakashima
RÉSUMÉ

In vitro screening of a Fe(2+) -chelating effect using a Fenton's reaction-luminol chemiluminescence (CL) system is described. The luminescence between the reactive oxygen species generated by the Fenton's reaction and luminol was decreased on capturing Fe(2+) using a chelator. The proposed method can prevent the consumption of expensive seed compounds (drug discovery candidates) owing to the high sensitivity of CL detection. Therefore, the assay could be performed using small volumes of sample solution (150 μL) at micromolar concentrations. After optimization of the screening conditions, the efficacies of conventional chelators such as ethylenediaminetetraacetic acid (EDTA), diethylentriaminepentaacetic acid (DETAPAC), deferoxamine, deferiprone and 1,10-phenanthroline were examined. EC50 values for these compounds (except 1,10-phenanthroline) were in the range 3.20 ± 0.87 to 9.57 ± 0.64 μM (n = 3). Rapid measurement of the Fe(2+)-chelating effect with an assay run time of a few minutes could be achieved using the proposed method. In addition, the specificity of the method was discussed.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1,10-Phenanthroline, ≥99%